How tiny particles from brain cells may trigger the immune system in Alzheimer’s
CNS Exosomes-Mediated Adaptive Immunity in Alzheimer's Disease (AD)
This project looks at whether small vesicles released by brain cells carry Alzheimer’s-related signals that activate the immune system in people with Alzheimer’s disease.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Tufts University Boston NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-11103395 on NIH RePORTER |
What this research studies
Researchers are testing whether brain-derived exosomes (small extracellular vesicles) carry Alzheimer’s-specific proteins that can stimulate T or B cells and drive immune responses. They will use genetically labeled mouse models that let scientists trace exosomes from specific brain cell types and follow where those exosomes travel in the body. The team will analyze the exosome contents and measure immune activation in peripheral organs to see if brain antigens reach and engage adaptive immune cells. Findings may point to new blood or immune markers and help explain how brain pathology interacts with the immune system in Alzheimer’s.
Who could benefit from this research
Good fit: People living with Alzheimer’s disease or mild cognitive impairment and their caregivers who follow advances in immune and biomarker research would be the most relevant audience for these findings.
Not a fit: People without Alzheimer’s or those whose conditions are driven by non-neurological causes are unlikely to gain direct benefit from this basic science project.
Why it matters
Potential benefit: If successful, this work could identify new immune-related biomarkers or targets that help guide future immune-based therapies for Alzheimer’s disease.
How similar studies have performed: Prior studies have linked innate immune cells and exosomes to Alzheimer’s, but showing that brain-derived exosomes trigger adaptive (T/B cell) responses is a newer and only partially explored idea.
Where this research is happening
Boston, United States
- Tufts University Boston — Boston, United States (Active)
Researchers
- Principal investigator: Yang, Yongjie — Tufts University Boston
- Study coordinator: Yang, Yongjie
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.